Related Experiment Video

Updated: Jul 16, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines

Claudia A Daubenberger1

  • 1Swiss Tropical Institute, Department of Medical Parasitology and Infection Biology, Socinstrasse 57, 4002 Basel, Switzerland. Claudia.Daubenberger@unibas.ch

Current Opinion in Molecular Therapeutics
|March 3, 2007
PubMed

Insights

Synthetic oligodeoxynucleotides targeting toll-like receptor 9 (TLR9) are potent vaccine adjuvants. These CpG oligodeoxynucleotides can program specific immune responses, advancing vaccine design for infectious diseases.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Effective pathogen elimination relies on distinct immune responses.
  • Vaccine adjuvants are crucial for directing immune response magnitude and quality.
  • Understanding adjuvant mechanisms is vital for rational vaccine design.

Purpose of the Study:

  • To explore the role of toll-like receptor 9 (TLR9) agonists in vaccine development.
  • To highlight the potential of CpG oligodeoxynucleotides as immunostimulatory agents.
  • To review recent advances in TLR9 agonist utility for vaccines.

Main Methods:

  • Investigated synthetic oligodeoxynucleotides with CpG motifs.
  • Focused on the interaction between CpG oligodeoxynucleotides and TLR9.
  • Reviewed literature on TLR9 agonists in vaccine applications.

Main Results:

  • CpG oligodeoxynucleotides act as potent immunostimulatory agents via TLR9 binding.
  • TLR9 activation programs specific immune responses.
  • CpG oligodeoxynucleotides show broad therapeutic and prophylactic vaccine potential.

Conclusions:

  • CpG oligodeoxynucleotides are valuable tools for vaccine adjuvant development.
  • Targeting TLR9 offers a promising strategy for enhancing vaccine efficacy.
  • Advances in TLR9 agonist research support their use in human and veterinary medicine.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...